Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

UPC

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:UPC
DateTimeSourceHeadlineSymbolCompany
02/25/20254:11PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
02/25/20254:10PMGlobeNewswire Inc.Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual ReportNASDAQ:UPCUniverse Pharmaceuticals Inc
02/20/20254:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
02/18/20254:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
02/11/20254:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
02/03/20254:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
02/03/20254:10PMGlobeNewswire Inc.Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing RequestNASDAQ:UPCUniverse Pharmaceuticals Inc
01/30/20258:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
01/27/20258:30AMEdgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNASDAQ:UPCUniverse Pharmaceuticals Inc
12/12/20244:31PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
12/10/20245:00PMGlobeNewswire Inc.Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)NASDAQ:UPCUniverse Pharmaceuticals Inc
12/09/20244:15PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:UPCUniverse Pharmaceuticals Inc
12/09/20247:00AMGlobeNewswire Inc.Universe Pharmaceuticals INC Announces $15 Million Registered Direct OfferingNASDAQ:UPCUniverse Pharmaceuticals Inc
11/13/20248:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
11/13/20248:00AMGlobeNewswire Inc.Universe Pharmaceuticals INC Announces Share ConsolidationNASDAQ:UPCUniverse Pharmaceuticals Inc
11/01/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
11/01/20244:00PMGlobeNewswire Inc.Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:UPCUniverse Pharmaceuticals Inc
10/10/20244:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
09/27/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
09/20/20244:15PMGlobeNewswire Inc.Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024NASDAQ:UPCUniverse Pharmaceuticals Inc
09/20/20244:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
09/03/20244:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
07/18/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
06/10/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UPCUniverse Pharmaceuticals Inc
05/14/20244:06PMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:UPCUniverse Pharmaceuticals Inc
02/07/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
01/30/20244:30PMPR Newswire (US)Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial ResultsNASDAQ:UPCUniverse Pharmaceuticals Inc
01/30/202412:05PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:UPCUniverse Pharmaceuticals Inc
08/31/20234:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
08/16/20234:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:UPC

Your Recent History

Delayed Upgrade Clock